EP1940379A4 - Methods for treatment of hemorrhagic shock and related disorders - Google Patents

Methods for treatment of hemorrhagic shock and related disorders

Info

Publication number
EP1940379A4
EP1940379A4 EP06850512A EP06850512A EP1940379A4 EP 1940379 A4 EP1940379 A4 EP 1940379A4 EP 06850512 A EP06850512 A EP 06850512A EP 06850512 A EP06850512 A EP 06850512A EP 1940379 A4 EP1940379 A4 EP 1940379A4
Authority
EP
European Patent Office
Prior art keywords
treatment
methods
related disorders
hemorrhagic shock
hemorrhagic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06850512A
Other languages
German (de)
French (fr)
Other versions
EP1940379A2 (en
Inventor
Elena V Koustova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Publication of EP1940379A2 publication Critical patent/EP1940379A2/en
Publication of EP1940379A4 publication Critical patent/EP1940379A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06850512A 2005-09-30 2006-10-02 Methods for treatment of hemorrhagic shock and related disorders Withdrawn EP1940379A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72197905P 2005-09-30 2005-09-30
PCT/US2006/038164 WO2007117272A2 (en) 2005-09-30 2006-10-02 Methods for treatment of hemorrhagic shock and related disorders

Publications (2)

Publication Number Publication Date
EP1940379A2 EP1940379A2 (en) 2008-07-09
EP1940379A4 true EP1940379A4 (en) 2009-05-13

Family

ID=38581510

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06850512A Withdrawn EP1940379A4 (en) 2005-09-30 2006-10-02 Methods for treatment of hemorrhagic shock and related disorders

Country Status (2)

Country Link
EP (1) EP1940379A4 (en)
WO (1) WO2007117272A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0818310A8 (en) * 2007-11-02 2017-12-26 Prometic Biosciences Inc GLYCERIDES AND MEDIUM CHAIN FATTY ACIDS AS NEPHROPROTECTIVE AGENTS
US9435813B2 (en) * 2010-05-11 2016-09-06 The General Hospital Corporation Biomarkers of hemorrhagic shock
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075839A2 (en) * 2002-03-04 2003-09-18 Aton Pharma, Inc. Methods of inducing terminal differentiation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476434A1 (en) * 2002-02-15 2003-08-28 Sloan-Kettering Institute For Cancer Research Method of treating trx mediated diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075839A2 (en) * 2002-03-04 2003-09-18 Aton Pharma, Inc. Methods of inducing terminal differentiation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KOUSTOVA E ET AL: "Ketone and pyruvate Ringer's solutions decrease pulmonary apoptosis in a rat model of severe hemorrhagic shock and resuscitation", SURGERY, C.V. MOSBY CO., ST. LOUIS, US, vol. 134, no. 2, 1 August 2003 (2003-08-01), pages 267 - 274, XP002339609, ISSN: 0039-6060 *

Also Published As

Publication number Publication date
WO2007117272A9 (en) 2007-12-06
WO2007117272A3 (en) 2008-07-31
EP1940379A2 (en) 2008-07-09
WO2007117272A2 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
EP1881823A4 (en) Compositions and methods for treatment of eye disorders
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
EP1853295A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1940441A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1861126A4 (en) Treatment of protein degradation disorders
ZA200707280B (en) Treatment of bone disorders
IL177772A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1893216A4 (en) Methods and compositions for the treatment of ocular disorders
PL1890684T3 (en) Treatment of sleep-wake disorders
EP1874286A4 (en) Methods and compositions for the treatment of anxiety disorders
EP1933880A4 (en) Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL180205A0 (en) Quinazolin - 4 - yl - piperidine and cinnolin - 4 - yl - piperidine derivatives as pde10 inhibitors for the treatment of cns disorders
IL190201A0 (en) Pde inhibitors and combinations thereof for the treatment of urological disorders
EP1901733A4 (en) Use of huperzine for disorders
EP1948675A4 (en) Methods and compositions for the treatment of marfan syndrome and associated disorders
ZA200706238B (en) Prevention and treatment of thromboembolic disorders
IL191537A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1996218A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL189009A0 (en) Methods and compositions for the treatment of neuropathies and related disorders
EP1885351A4 (en) Methods and compositions for the treatment of pain
HK1121378A1 (en) Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
EP1898921A4 (en) Compositions and methods for treating sleep disorders
EP1901770A4 (en) Methods for treatment of growth disorders
EP1940379A4 (en) Methods for treatment of hemorrhagic shock and related disorders

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080327

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20080731

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/33 20060101AFI20080821BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090416

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 43/00 20060101ALI20090408BHEP

Ipc: A61P 7/00 20060101ALI20090408BHEP

Ipc: A61K 31/192 20060101ALI20090408BHEP

Ipc: A61K 31/19 20060101ALI20090408BHEP

Ipc: A61K 31/135 20060101AFI20090408BHEP

17Q First examination report despatched

Effective date: 20090723

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100203